FDA Form 483 Inspection Observations and Responses
Summary
This practice note provides practical guidance for responding to Form 483 inspectional observations issued by investigator from the Food and Drug Administration (FDA) following a drug or medical device facility inspection. It outlines key points to discuss with a pharmaceutical or medical device company client after its facility has been inspected by the FDA.